BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim J, Lee J, Oh JH, Chang HJ, Sohn DK, Shin A, Kim J. Plasma inflammatory biomarkers and modifiable lifestyle factors associated with colorectal cancer risk. Clin Nutr 2020;39:2778-85. [PMID: 31883943 DOI: 10.1016/j.clnu.2019.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Fang Z, Hang D, Wang K, Joshi A, Wu K, Chan AT, Ogino S, Giovannucci EL, Song M. Risk prediction models for colorectal cancer: Evaluating the discrimination due to added biomarkers. Int J Cancer 2021;149:1021-30. [PMID: 33948940 DOI: 10.1002/ijc.33621] [Reference Citation Analysis]
2 Gerada C, Ryan KM. Autophagy, the innate immune response and cancer. Mol Oncol 2020;14:1913-29. [PMID: 32745353 DOI: 10.1002/1878-0261.12774] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
3 Chang J, Zhang W, Lin G, Tong D, Zhu D, Zhao J, Yu Q, Huang D, Li W. Tumor Response to Irinotecan is Associated with IL-10 Expression Level in Metastatic Colorectal Cancer-Results from mCRC Biomarker Study. Onco Targets Ther 2020;13:11819-26. [PMID: 33235468 DOI: 10.2147/OTT.S275636] [Reference Citation Analysis]
4 Lu H, Wu PF, Zhang W, Liao X. Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study. Front Immunol 2021;12:647588. [PMID: 33936066 DOI: 10.3389/fimmu.2021.647588] [Reference Citation Analysis]